Solid Biosciences Inc (SLDB)
8.25
+0.61
(+7.98%)
USD |
NASDAQ |
May 31, 16:00
8.22
-0.03
(-0.36%)
Pre-Market: 20:00
Solid Biosciences Cash and Short Term Investments (Quarterly): 206.07M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 206.07M |
December 31, 2023 | 123.64M |
September 30, 2023 | 142.88M |
June 30, 2023 | 160.19M |
March 31, 2023 | 185.51M |
December 31, 2022 | 213.72M |
September 30, 2022 | 142.16M |
June 30, 2022 | 162.88M |
March 31, 2022 | 180.05M |
December 31, 2021 | 207.78M |
September 30, 2021 | 229.76M |
June 30, 2021 | 248.96M |
March 31, 2021 | 268.50M |
December 31, 2020 | 154.74M |
Date | Value |
---|---|
September 30, 2020 | 24.80M |
June 30, 2020 | 40.44M |
March 31, 2020 | 53.59M |
December 31, 2019 | 83.52M |
September 30, 2019 | 105.66M |
June 30, 2019 | 67.39M |
March 31, 2019 | 94.74M |
December 31, 2018 | 122.46M |
September 30, 2018 | 145.37M |
June 30, 2018 | 162.76M |
March 31, 2018 | 182.38M |
December 31, 2017 | 69.09M |
September 30, 2017 | 29.57M |
December 31, 2016 | 37.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
24.80M
Minimum
Sep 2020
268.50M
Maximum
Mar 2021
150.11M
Average
157.47M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 1.391B |
PTC Therapeutics Inc | 884.81M |
Capricor Therapeutics Inc | 39.92M |
Catalyst Pharmaceuticals Inc | 310.41M |
Pfizer Inc | 11.93B |